Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
Author(s) -
Sara Alosaimy,
Taylor Morrisette,
Abdalhamid M Lagnf,
Leonor M. Rojas,
Madeline King,
Benjamin Pullinger,
Athena L V Hobbs,
Nicholson B. Perkins,
Michael P. Veve,
Jeannette Bouchard,
Tristan Gore,
Bruce M Jones,
James Truong,
Justin Andrade,
Glen Huang,
Reese Cosimi,
S. Lena KangBirken,
Kyle C. Molina,
Mark Biagi,
Michael Pierce,
Marco R. Scipione,
Jing Zhao,
Susan L. Davis,
Michael J. Rybak
Publication year - 2022
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.00479-22
Subject(s) - acinetobacter baumannii , carbapenem , medicine , guideline , acinetobacter , microbiology and biotechnology , intensive care medicine , antibiotics , biology , pseudomonas aeruginosa , bacteria , pathology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom